Armistice Capital »

Collplant Biotechnologies Lt shares owned by Armistice Capital

Quarter-by-quarter ownership of Collplant Biotechnologies Lt (CLGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Collplant Biotechnologies Lt

Tip: Access up to 7 years of quarterly data

All positions including Collplant Biotechnologies Lt held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Collplant Biotechnologies Lt by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $34k 64k 0.54

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Collplant Biotechnologies Lt

St. Denis J. Villere & Co
Gail Mannix
Brown Advisory Holdings Incorporated
Armistice Capital
Pathstone Holdings
Citadel Advisors
Legacy Wealth Managment
Renaissance Technologies
XTX Topco
Waters, Parkerson & Co
Virtu Financial
Two Sigma Securities
FNY Investment Advisers
Group One Trading
Advisor Group Holdings

View all funds holding Collplant Biotechnologies Lt